These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37311279)

  • 21. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.
    Lan Q; Wang C; Zhou J; Wang L; Jiao F; Zhang Y; Cai Y; Lu L; Xia S; Jiang S
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteolin Isolated from
    Hakem A; Desmarets L; Sahli R; Malek RB; Camuzet C; François N; Lefèvre G; Samaillie J; Moureu S; Sahpaz S; Belouzard S; Ksouri R; Séron K; Rivière C
    Molecules; 2023 May; 28(11):. PubMed ID: 37298740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
    Weil T; Lawrenz J; Seidel A; Münch J; Müller JA
    Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
    Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
    Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.
    Xie P; Fang Y; Shen Z; Shao Y; Ma Q; Yang Z; Zhao J; Li H; Li R; Dong S; Wen W; Xia X
    Phytomedicine; 2021 Dec; 93():153808. PubMed ID: 34753027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molnupiravir and Its Antiviral Activity Against COVID-19.
    Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
    Front Immunol; 2022; 13():855496. PubMed ID: 35444647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.
    Jonsdottir HR; Siegrist D; Julien T; Padey B; Bouveret M; Terrier O; Pizzorno A; Huang S; Samby K; Wells TNC; Boda B; Rosa-Calatrava M; Engler OB; Constant S
    Biomed Pharmacother; 2022 Jun; 150():113058. PubMed ID: 35658229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
    Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides.
    Hu Y; Zhu Y; Yu Y; Liu N; Ju X; Ding Q; He Y
    Antiviral Res; 2023 Apr; 212():105571. PubMed ID: 36868315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.
    Pasquereau S; Nehme Z; Haidar Ahmad S; Daouad F; Van Assche J; Wallet C; Schwartz C; Rohr O; Morot-Bizot S; Herbein G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
    Dijkman R; Verma AK; Selvaraj M; Ghimire R; Gad HH; Hartmann R; More S; Perlman S; Thiel V; Channappanavar R
    J Virol; 2022 Jun; 96(11):e0036422. PubMed ID: 35588276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines.
    Bezerra BB; Silva GPDD; Coelho SVA; Correa IA; Souza MRM; Macedo KVG; Matos BM; Tanuri A; Matassoli FL; Costa LJD; Hildreth JEK; Arruda LB
    Antiviral Res; 2022 Sep; 205():105373. PubMed ID: 35798224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
    Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S
    Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral Potential of Azelastine against Major Respiratory Viruses.
    Fischhuber K; Bánki Z; Kimpel J; Kragl N; Rössler A; Bolze A; Muellauer B; Angerer J; Nagy G; Nagy E; Szijarto V
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
    Yan H; Sun J; Wang K; Wang H; Wu S; Bao L; He W; Wang D; Zhu A; Zhang T; Gao R; Dong B; Li J; Yang L; Zhong M; Lv Q; Qin F; Zhuang Z; Huang X; Yang X; Li Y; Che Y; Jiang J
    Acta Pharm Sin B; 2021 Sep; 11(9):2850-2858. PubMed ID: 33723501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
    Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.